Company: SONM
Filing Date: 2025-10-20
Form Type: 8-K
Source: 0001493152-25-018637
Chunk: 0

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-10-20
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As
disclosed in the Current Report on Form 8-K of Sonim Technologies, Inc. (the “ Company”) filed with the Securities and Exchange
Commission (the “ SEC”), on August 22, 2025, the Company received a letter (the “ Deficiency Letter”)
from The Nasdaq Stock Market LLC (“ Nasdaq”) indicating that the Company’s stockholders’ equity, as reported in
its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “ Form 10-Q”), did not satisfy the continued listing
requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholders’
equity be at least $2.5 million.

On
October 6, 2025, the Company submitted to the Nasdaq staff a plan to regain compliance with Nasdaq Listing Rule 5550(b)(1).

On
October 17, 2025, the Company received written notification from Nasdaq (the “ Extension Notice”) granting the Company an
extension through December 31, 2025, to regain compliance with Nasdaq Listing Rule 5550(b)(1). Under the terms of the extension, on or
before December 31, 2025, the Company must evidence compliance with Nasdaq Listing Rule 5550(b)(1) as set forth in the Extension Notice.
The Company intends to satisfy these requirements within the current extension period or, if necessary, to request a further extension
from Nasdaq, which would be subject to Nasdaq’s discretion.

The
Company is undertaking measures to regain compliance within the extension period; however, there can be no assurance that the Company
will ultimately regain compliance with Nasdaq Listing Rule 5550(b)(1) or be able to maintain compliance with all other applicable requirements
for continued listing on Nasdaq. The Company’s failure to meet these requirements could result in the Company’s securities
being delisted from Nasdaq.

Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

Executive
Chairman Appointment

On
October 16, 2025, the board of directors (the “ Board”) of the Company appointed Mr. Michael Mulica to serve as